Literature DB >> 23542163

Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice.

Ying Dai1, Tomas Kiselak, Joanne Clark, Elizabeth Clore, Kangni Zheng, Allen Cheng, Gregory C Kujoth, Tomas A Prolla, Eleftheria Maratos-Flier, David K Simon.   

Abstract

The mitochondrial DNA (mtDNA) polymerase γ (POLG) mutator mice provide the first experimental evidence that high levels of somatic mtDNA mutations can be functionally significant. Here we report that older homozygous, but not heterozygous, POLG mice show significant reductions in striatal dopaminergic terminals as well as deficits in motor function. However, resting oxygen consumption, heat production, mtDNA content and mitochondrial electron transport chain activities are significantly decreased at older ages in both homozygous and heterozygous mice. These results indicate that high levels of somatic mtDNA mutations can contribute to dopaminergic dysfunction and to behavioral and metabolic deficits.
Copyright © 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542163      PMCID: PMC3682692          DOI: 10.1016/j.mito.2013.03.006

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  48 in total

1.  Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

Authors:  Petri Luoma; Atle Melberg; Juha O Rinne; Jyrki A Kaukonen; Nina N Nupponen; Richard M Chalmers; Anders Oldfors; Ilkka Rautakorpi; Leena Peltonen; Kari Majamaa; Hannu Somer; Anu Suomalainen
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

2.  Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging.

Authors:  G C Kujoth; A Hiona; T D Pugh; S Someya; K Panzer; S E Wohlgemuth; T Hofer; A Y Seo; R Sullivan; W A Jobling; J D Morrow; H Van Remmen; J M Sedivy; T Yamasoba; M Tanokura; R Weindruch; C Leeuwenburgh; T A Prolla
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

3.  Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.

Authors:  N Hattori; M Tanaka; T Ozawa; Y Mizuno
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

4.  Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys.

Authors:  M E Emborg; S Y Ma; E J Mufson; A I Levey; M D Taylor; W D Brown; J E Holden; J H Kordower
Journal:  J Comp Neurol       Date:  1998-11-16       Impact factor: 3.215

5.  Does premature aging of the mtDNA mutator mouse prove that mtDNA mutations are involved in natural aging?

Authors:  Konstantin Khrapko; Yevgenya Kraytsberg; Aubrey D N J de Grey; Jan Vijg; Eric A Schon
Journal:  Aging Cell       Date:  2006-06       Impact factor: 9.304

6.  Morphometry of the human substantia nigra in ageing and Parkinson's disease.

Authors:  Gay Rudow; Richard O'Brien; Alena V Savonenko; Susan M Resnick; Alan B Zonderman; Olga Pletnikova; Laura Marsh; Ted M Dawson; Barbara J Crain; Mark J West; Juan C Troncoso
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

7.  Age-correlated loss of dopaminergic binding sites in human basal ganglia.

Authors:  J A Severson; J Marcusson; B Winblad; C E Finch
Journal:  J Neurochem       Date:  1982-12       Impact factor: 5.372

8.  Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.

Authors:  Michael K Badman; Anja Koester; Jeffrey S Flier; Alexei Kharitonenkov; Eleftheria Maratos-Flier
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction.

Authors:  Michael L Chen; T Daniel Logan; Maryann L Hochberg; Suresh G Shelat; Xiang Yu; Gregory E Wilding; Wei Tan; Gregory C Kujoth; Tomas A Prolla; Mary A Selak; Mondira Kundu; Martin Carroll; James E Thompson
Journal:  Blood       Date:  2009-09-04       Impact factor: 22.113

10.  Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.

Authors:  James B Koprich; Casper Reske-Nielsen; Prabhakar Mithal; Ole Isacson
Journal:  J Neuroinflammation       Date:  2008-02-27       Impact factor: 8.322

View more
  20 in total

1.  Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain.

Authors:  Joanne Clark-Matott; Ayesha Saleem; Ying Dai; Yevgeniya Shurubor; Xiaoxing Ma; Adeel Safdar; Myron Flint Beal; Mark Tarnopolsky; David K Simon
Journal:  Neurobiol Aging       Date:  2015-07-21       Impact factor: 4.673

Review 2.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

3.  Somatic mitochondrial DNA mutations do not increase neuronal vulnerability to MPTP in young POLG mutator mice.

Authors:  Ying Dai; Joanne Clark; Kangni Zheng; Gregory C Kujoth; Tomas A Prolla; David K Simon
Journal:  Neurotoxicol Teratol       Date:  2014 Nov-Dec       Impact factor: 3.763

4.  Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.

Authors:  Alicia M Pickrell; Chiu-Hui Huang; Scott R Kennedy; Alban Ordureau; Dionisia P Sideris; Jake G Hoekstra; J Wade Harper; Richard J Youle
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

5.  High-fat diet and FGF21 cooperatively promote aerobic thermogenesis in mtDNA mutator mice.

Authors:  Christopher E Wall; Jamie Whyte; Jae M Suh; Weiwei Fan; Brett Collins; Christopher Liddle; Ruth T Yu; Annette R Atkins; Jane C Naviaux; Kefeng Li; Andrew Taylor Bright; William A Alaynick; Michael Downes; Robert K Naviaux; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

Review 6.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 7.  Mitochondrial dynamics and transport in Alzheimer's disease.

Authors:  Padraig J Flannery; Eugenia Trushina
Journal:  Mol Cell Neurosci       Date:  2019-06-16       Impact factor: 4.314

Review 8.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

9.  Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation.

Authors:  Ying Dai; Kangni Zheng; Joanne Clark; Russell H Swerdlow; Stefan M Pulst; James P Sutton; Leslie A Shinobu; David K Simon
Journal:  Hum Mol Genet       Date:  2013-09-18       Impact factor: 6.150

Review 10.  Parkinson's disease as a result of aging.

Authors:  Manuel Rodriguez; Clara Rodriguez-Sabate; Ingrid Morales; Alberto Sanchez; Magdalena Sabate
Journal:  Aging Cell       Date:  2015-02-09       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.